The aim of this study was to assess the efficacy of temozolomide in patients with World Health Organisation (WHO) grade II gliomas treated with surgery alone using imaging and clinical criteria.
Neuro-Oncology Unit, The Royal Marsden NHS Trust, and Academic Unit of Radiotherapy and Oncology, The Institute of Cancer Research, Sutton, Surrey, UK. frada@icr.ac.uk